Johnson Financial Group LLC (Colorado)’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.52M Buy
6,992
+2,609
+60% +$579K 0.1% 45
2025
Q4
$1M Buy
4,383
+2,104
+92% +$479K 0.06% 52
2025
Q3
$528K Hold
2,279
0.05% 47
2025
Q2
$423K Sell
2,279
-170
-7% -$31.6K 0.04% 49
2025
Q1
$513K Buy
+2,449
New +$476K 0.05% 48
2022
Q2
Sell
-1,253
Closed -$203K 51
2022
Q1
$203K Buy
+1,253
New +$182K 0.03% 46
2018
Q1
$327K Buy
+3,457
New +$380K 0.27% 32

Other funds holding ABBV

Johnson Financial Group LLC (Colorado)'s ABBV Position: Q1 2026 in Review

Johnson Financial Group LLC (Colorado) increased its AbbVie (ABBV) stake by 60% in Q1 2026, buying an estimated $579K and bringing the position to 6,992 shares worth $1.52M. The position accounts for 0.1% of the portfolio, ranked #45.

Johnson Financial Group LLC (Colorado) first reported a position in ABBV in Q1 2018 and has held it in 7 quarters since. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Johnson Financial Group LLC (Colorado) held 6,992 shares of AbbVie worth $1.52M as of Q1 2026.
  • Johnson Financial Group LLC (Colorado) bought 2,609 AbbVie shares in Q1 2026, an estimated $579K.
  • AbbVie made up 0.1% of Johnson Financial Group LLC (Colorado)'s portfolio in Q1 2026, its #45 holding.
  • Johnson Financial Group LLC (Colorado) first reported a position in AbbVie in Q1 2018 and has held it in 7 quarters since.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Johnson Financial Group LLC (Colorado)'s 13F filing for Q1 2026, filed 14 May 2026.